U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06944236) titled 'CKM Syndrome Prevalence and Its Association With SCORE-2 and BRI' on April 17.
Brief Summary: This cross-sectional study aims to determine the prevalence of Cardiovascular-Kidney-Metabolic (CKM) syndrome in a community-based adult population in Gaziantep, Turkiye. In addition to estimating the prevalence across CKM stages, the study investigates the associations between CKM syndrome and two key risk indicators: the SCORE-2 cardiovascular risk score and Body Roundness Index (BRI). Findings from this study will provide valuable insights into early cardiometabolic risk profiling and support the development of regionally tailored preve...